Susquehanna International Group, LLP Insulet Corp Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$163.6 - $209.11 $10.2 Million - $13 Million	62,300 Added 41.84%	211,200 $36.2 Million
Q4 2023 Feb 14, 2024	SELL	$127.77 - $221.42 $3.83 Million - $6.64 Million	-30,000 Reduced 16.77%	148,900 $32.3 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $11.5 Million - $21.6 Million	74,300 Added 71.03%	178,900 $28.5 Million
Q2 2023 Aug 11, 2023	SELL	$272.48 - $330.23 $9.56 Million - $11.6 Million	-35,100 Reduced 25.13%	104,600 $30.2 Million
Q1 2023 May 16, 2023	BUY	$276.36 - $326.03 $7.43 Million - $8.77 Million	26,900 Added 23.85%	139,700 $44.6 Million

Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $6.43 Million - $9.5 Million	30,300 Added 36.73%	112,800 $33.2 Million
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $3.5 Million - $4.39 Million	15,600 Added 23.32%	82,500 $18.9 Million

613

62.9M

339K

916K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $14B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.